Joincare Pharmaceutical Group Industry Co.,Ltd.

Shanghai Stock Exchange:600380.SS

Sector

🏥 Health Care

Industries

🧴 Personal Care

🔬 Clinical Trials

💄 Cosmetics

💊 Pharmaceuticals

💻 Telehealth

Location

China

Market Cap

USD 2.80 B

Share Price

USD 1.53

Avg Daily Volume

17,005,600

Change (1 day)

0.80%

Change (1 year)

-1.73%

Change (YTD)

-0.70%

Joincare Pharmaceutical Group Industry Co.,Ltd. Operating Income Margin for the year ending December 31, 2024: 23.15%

Joincare Pharmaceutical Group Industry Co.,Ltd. Operating Income Margin is 23.15% for the year ending December 31, 2024, a 9.91% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Joincare Pharmaceutical Group Industry Co.,Ltd. Operating Income Margin for the year ending December 31, 2023 was 21.07%, a 3.77% change year over year.
Joincare Pharmaceutical Group Industry Co.,Ltd. Operating Income Margin for the year ending December 31, 2022 was 20.30%, a 8.22% change year over year.
Joincare Pharmaceutical Group Industry Co.,Ltd. Operating Income Margin for the year ending December 31, 2021 was 18.76%, a -14.69% change year over year.
Joincare Pharmaceutical Group Industry Co.,Ltd. Operating Income Margin for the year ending December 31, 2020 was 21.99%, a 20.43% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Operating Income Margin	Gross Profit Margin	EBIT Margin	EBITDA Margin

Shanghai Stock Exchange: 600380.SS

Joincare Pharmaceutical Group Industry Co.,Ltd.

CEO	Mr. Zhiwei Xing
IPO Date	June 8, 2001
Location	China
Headquarters	Joincare Pharmaceutical Group Building
Employees	14,350
Sector	🏥 Health Care
Industries Personal Care 🔬 Clinical Trials 💄 Cosmetics 💊 Pharmaceuticals 💻 Telehealth

Description

Joincare Pharmaceutical Group Industry Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and healthcare products primarily in China. The company offers chemical drug preparation products, including respiration, gastroenterology, anti-infection, gonadotropic, and psychiatric products; and traditional chinese drug preparation production, which includes anti-tumor and cold products. It also provides chemical APIs and intermediates; diagnostic reagents and equipment, including autoimmunity multiple detection platform and diagnostic kit for IgM; and healthcare products, which includes American ginseng tea and Jingxin menocare essence. In addition, the company engages in the wholesale and retail of skin care products, cosmetics, and other necessities. It offers its products in various forms, such as hormone tablets, oral liquids, and tablets. The company was founded in 1992 and is headquartered in Shenzhen, China.